2 weeks Ago By Defense World Staff
Wells Fargo & Company MN cut its holdings in shares of Invesco Pharmaceuticals ETF ( NYSEARCA:PJP – Free Report ) by 0.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,659 shares of the company’s stock after selling 140 shares during the period.
Wells Fargo & Company MN owned about 0.82% of Invesco Pharmaceuticals ETF worth $2,285,000 at the end of the most recent quarter. A number of other hedge funds and other institutional investors have also recently bought and sold shares of PJP.
MGB Wealth Management LLC increased its holdings in shares of Invesco Pharmaceuticals ETF by 11.9% in the fourth quarter. MGB Wealth Management LLC now owns 21,976 shares of the company’s stock valued at $1,815,000 after purchasing an additional 2,345 shares in the last quarter.
Joseph Group Capital Management boosted its position in Invesco Pharmaceuticals ETF by 15.4% in the 4th quarter. Joseph Group Capital Management now owns 17,397 shares of the company’s stock valued at $1,437,000 after buying an additional 2,317 shares during the last quarter.
Jane Street Group LLC bought a new position in Invesco Pharmaceuticals ETF in the 3rd quarter valued at $1,163,000. Raymond James Financial Inc. acquired a new stake in shares of Invesco Pharmaceuticals ETF in the 4th quarter valued at $943,000.
Finally, Commonwealth Retirement Investments LLC bought a new stake in shares of Invesco Pharmaceuticals ETF during the fourth quarter worth $401,000. Invesco Pharmaceuticals ETF Stock Up 0.6 % Invesco Pharmaceuticals ETF stock opened at $79.
85 on Friday. The business’s 50-day simple moving average is $82.51 and its 200 day simple moving average is $84.
48. The stock has a market cap of $240.35 million, a price-to-earnings ratio of 19.
60 and a beta of 0.56. Invesco Pharmaceuticals ETF has a 12-month low of $72.
25 and a 12-month high of $89.87. Invesco Pharmaceuticals ETF Company Profile PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund.
The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Read More Five stocks we like better than Invesco Pharmaceuticals ETF Utilities Stocks Explained – How and Why to Invest in Utilities Short Sellers Gave Up on These 3 Names Recently How to Evaluate a Stock Before Buying 3 Boring Stocks Outperforming the Market This Year Transportation Stocks Investing If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.
com's FREE daily email newsletter ..
